Innovative Eyewear (LUCY) Asset Writedowns and Impairment (2021 - 2025)
Innovative Eyewear (LUCY) posted Asset Writedowns and Impairment of $4364.0 for Q4 2025, up 206.03% sequentially from -$4116.0 in Q3 2025, and down 80.57% YoY from $22464.0 in Q4 2024.
Innovative Eyewear (LUCY) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Innovative Eyewear has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $4364.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment fell 80.57% year-over-year to $4364.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7993.0 (down 59.75% YoY) and the FY2025 annual result came in at $7993.0, down 59.75% from the prior year.
- Asset Writedowns and Impairment climbed to $4364.0 in Q4 2025 per LUCY's latest filing, from -$4116.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $105171.0 in Q4 2022 and troughed at -$38621.0 in Q4 2021.
- A 5-year average of $7001.3 and a median of $2784.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment slumped 3544.37% in 2024, then soared 470.18% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at -$38621.0 in 2021, then surged by 372.32% to $105171.0 in 2022, then slumped by 132.9% to -$34604.0 in 2023, then surged by 164.92% to $22464.0 in 2024, then plunged by 80.57% to $4364.0 in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $4364.0, -$4116.0, and $6865.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Innovative Eyewear | 4.37 Mn | 1.91 Mn | 242,515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,364.00 |
| Dec 31, 2025 | 4,364.00 |
| Sep 30, 2025 | -4,116.00 |
| Sep 30, 2025 | -4,116.00 |
| Jun 30, 2025 | 6,865.00 |
| Jun 30, 2025 | 6,865.00 |
| Mar 31, 2025 | 880.00 |
| Mar 31, 2025 | 880.00 |
| Dec 31, 2024 | 22,464.00 |
| Dec 31, 2024 | 22,464.00 |
| Sep 30, 2024 | 1,082.00 |
| Sep 30, 2024 | 1,082.00 |
| Jun 30, 2024 | 1,204.00 |
| Jun 30, 2024 | 1,204.00 |
| Mar 31, 2024 | -4,891.00 |
| Mar 31, 2024 | -4,891.00 |
| Dec 31, 2023 | -34,604.00 |
| Dec 31, 2023 | -34,604.00 |
| Sep 30, 2023 | 14,065.00 |
| Sep 30, 2023 | 14,065.00 |